Gates, Milner Back Cancer-Genetics Startup

Microsoft Corp. (MSFT) co-founder Bill Gates and Russian billionaire Yuri Milner invested in genetics startup Foundation Medicine Inc., joining prior backers including Google Ventures and Kleiner Perkins Caufield & Byers.

Gates and Milner helped Foundation raise an additional $13.5 million in an expansion of its Series B financing, bringing the total raised in the round to $56 million, the Cambridge, Massachusetts-based company said today in a statement. Evan Jones, co-founder of Digene Corp., participated in the financing and will join Foundation’s board.

Foundation makes tools that can inspect DNA to determine individuals’ risk of cancer and help doctors make treatment decisions.

To contact the reporter on this story: Lisa Rapaport in New York at

To contact the editor responsible for this story: Lisa Rapaport at

Press spacebar to pause and continue. Press esc to stop.

Bloomberg reserves the right to remove comments but is under no obligation to do so, or to explain individual moderation decisions.

Please enable JavaScript to view the comments powered by Disqus.